Lerodalcibep, Placebo matching lerodalcibep, solution for injection in pre-filled pen/injector clinical trials

Randomized, Placebo-Controlled, Double-Blind, Phase 3b Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children and Adolescents, 6 to 17 Years of Age, with Heterozygous Familial Hypercholesterolemia on Stable Diet and Oral Lipid-Lowering Therapy (LIBerate-Kids)

This study looks at a new medicine called lerodalcibep for children and teenagers aged 6 to 17 with a genetic condition causing high cholesterol (Heterozygous Familial Hypercholesterolemia). It aims to see if the medicine can lower their cholesterol safely and effectively, compared to a dummy medicine.